GSK Is First To Share Cancer Drug Patents With Poor Countries
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline to license its future cancer treatments for generic manufacturing in poor countries; access continues to be flagship issue for GSK's Witty, who also sits on recently formed UN access panel.